Six immunology companies revolutionizing immune treatments

Recent investment in the biopharma industry has highlighted immunology as a key area of focus. This report discusses six biotech companies, AltruBio, Capstan Therapeutics, Lycia Therapeutics, Mirador Therapeutics, Santa Ana Bio, and Uniquity Bio that have attracted significant funding for their immunology-related R&D. With multiple buyouts of immunology and inflammation drug developers and impressive financial injections to support drug development, the global immunology market is expected to grow from $103.18 billion in 2024 to $257.39 billion by 2032.